11-73825725-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000310614.12(MRPL48):c.130A>T(p.Ile44Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000249 in 1,564,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000310614.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL48 | NM_016055.6 | c.130A>T | p.Ile44Phe | missense_variant | 4/8 | ENST00000310614.12 | NP_057139.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL48 | ENST00000310614.12 | c.130A>T | p.Ile44Phe | missense_variant | 4/8 | 1 | NM_016055.6 | ENSP00000308717.7 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000559 AC: 1AN: 178786Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 94626
GnomAD4 exome AF: 0.0000248 AC: 35AN: 1412016Hom.: 0 Cov.: 30 AF XY: 0.0000229 AC XY: 16AN XY: 697652
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2024 | The c.130A>T (p.I44F) alteration is located in exon 4 (coding exon 4) of the MRPL48 gene. This alteration results from a A to T substitution at nucleotide position 130, causing the isoleucine (I) at amino acid position 44 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at